Jing Wen1, Xueli Cai2, Jie Zhang1,3, Jiajia Jiang1, Wei Li1, Guangxu Liu1, Meiping Wang1, Herbert Y Gaisano4, Yuesong Pan5,6, Yan He7,8. 1. Department of Epidemiology and Biostatistics, School of Public Health, Capital Medical University, Beijing, China. 2. Department of Neurology, Lishui Municipal Central Hospital, Lishui, Zhejiang, China. 3. Municipal Key Laboratory of Clinical Epidemiology, Beijing, China. 4. Department of Medicine, University of Toronto, Toronto, Canada. 5. China National Clinical Research Center for Neurological Diseases, Beijing, China. yuesongpan@ncrcnd.org.cn. 6. Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. yuesongpan@ncrcnd.org.cn. 7. Department of Epidemiology and Biostatistics, School of Public Health, Capital Medical University, Beijing, China. yanhe118@sina.com. 8. Municipal Key Laboratory of Clinical Epidemiology, Beijing, China. yanhe118@sina.com.
Abstract
PURPOSE: The degree of adipose tissue insulin resistance increases in obesity, prediabetes and type 2 diabetes, but whether it associates with prediabetes is unclear. METHODS: This is a cross-sectional study of 426 participants. The degree of adipose tissue insulin resistance was assessed using the index of adipose tissue insulin resistance (Adipo-IRI), calculated as the product of fasting insulin and free fatty acids. The association of adipose tissue insulin resistance and prediabetes was assessed by multivariate logistic regression. Area under curves (AUCs) of receiver operating characteristic cure analyses were calculated to assess their diagnostic value in distinguishing prediabetes of the following: insulin resistance in the adipose tissue and peripheral tissue, general and abdominal obesity, and elevated triglycerides. RESULTS: The median age of the participants was 59 years with males accounting for 47.7%. After adjustment for potential confounding factors, Adipo-IRI was associated with prediabetes and its phenotypes in both genders. The diagnostic value of adipose tissue insulin resistance (AUC, male: 0.71 (95% CI, 0.65-0.77) and female: 0.74 (95% CI, 0.68-0.95)) for prediabetes were superior or similar to peripheral tissue insulin resistance, body mass index, waist circumference and triglycerides. CONCLUSIONS: Adipose tissue insulin resistance is associated with prediabetes and should be considered for use in population studies.
PURPOSE: The degree of adipose tissue insulin resistance increases in obesity, prediabetes and type 2 diabetes, but whether it associates with prediabetes is unclear. METHODS: This is a cross-sectional study of 426 participants. The degree of adipose tissue insulin resistance was assessed using the index of adipose tissue insulin resistance (Adipo-IRI), calculated as the product of fasting insulin and free fatty acids. The association of adipose tissue insulin resistance and prediabetes was assessed by multivariate logistic regression. Area under curves (AUCs) of receiver operating characteristic cure analyses were calculated to assess their diagnostic value in distinguishing prediabetes of the following: insulin resistance in the adipose tissue and peripheral tissue, general and abdominal obesity, and elevated triglycerides. RESULTS: The median age of the participants was 59 years with males accounting for 47.7%. After adjustment for potential confounding factors, Adipo-IRI was associated with prediabetes and its phenotypes in both genders. The diagnostic value of adipose tissue insulin resistance (AUC, male: 0.71 (95% CI, 0.65-0.77) and female: 0.74 (95% CI, 0.68-0.95)) for prediabetes were superior or similar to peripheral tissue insulin resistance, body mass index, waist circumference and triglycerides. CONCLUSIONS: Adipose tissue insulin resistance is associated with prediabetes and should be considered for use in population studies.
Authors: Laura C Plantinga; Deidra C Crews; Josef Coresh; Edgar R Miller; Rajiv Saran; Jerry Yee; Elizabeth Hedgeman; Meda Pavkov; Mark S Eberhardt; Desmond E Williams; Neil R Powe Journal: Clin J Am Soc Nephrol Date: 2010-03-25 Impact factor: 8.237
Authors: N Sarwar; P Gao; S R Kondapally Seshasai; R Gobin; S Kaptoge; E Di Angelantonio; E Ingelsson; D A Lawlor; E Selvin; M Stampfer; C D A Stehouwer; S Lewington; L Pennells; A Thompson; N Sattar; I R White; K K Ray; J Danesh Journal: Lancet Date: 2010-06-26 Impact factor: 202.731
Authors: Robyn J Tapp; Gabriella Tikellis; Tien Y Wong; C Alex Harper; Paul Z Zimmet; Jonathan E Shaw Journal: Diabetes Care Date: 2008-04-14 Impact factor: 19.112
Authors: M J Armstrong; J M Hazlehurst; D Hull; K Guo; S Borrows; J Yu; S C Gough; P N Newsome; J W Tomlinson Journal: Diabetes Obes Metab Date: 2014-03-11 Impact factor: 6.577
Authors: Ricardo J Samms; Christine C Cheng; Marcel Fourcaudot; Sami Heikkinen; Ahmed Khattab; John Adams; Eugenio Cersosimo; Curtis Triplitt; Curtis Puckett; Kostas Tsintzas; Andrew C Adams; Muhammad A Abdul-Ghani; Ralph A DeFronzo; Luke Norton Journal: Am J Physiol Endocrinol Metab Date: 2022-06-20 Impact factor: 5.900
Authors: Shelley A Cole; Hugo A Laviada-Molina; Jeannette M Serres-Perales; Ernesto Rodriguez-Ayala; Raul A Bastarrachea Journal: Pathogens Date: 2020-05-19